一种用于加强前列腺癌确诊退伍军人护理的系统工程与决策支持工具。
A Systems Engineering and Decision-Support Tool to Enhance Care of Veterans Diagnosed With Prostate Cancer.
作者信息
Chang Michael G, DeSotto Kristine, Taibi Paul, Troeschel Sandra
机构信息
is the service chief of the Radiation Oncology section and is a nurse practitioner, both at the Hunter Holmes McGuire VAMC in Richmond, Virginia. is an industrial engineer with the New England Veterans Engineering Resource Center in Boston, Massachusetts. is a biostatistician with the Pittsburgh Veterans Engineering Resource Center in Pittsburgh, Pennsylvania.
出版信息
Fed Pract. 2016 Feb;33(Suppl 1):57S-60S.
Abstract
A prostate-specific antigen tracking system identifies patients who require intervention before they present with clinical problems, ensuring that testing occurs at appropriate intervals.
摘要
一种前列腺特异性抗原追踪系统能够在患者出现临床问题之前识别出需要干预的患者，确保检测能以适当的间隔进行。
相似文献
1
A Systems Engineering and Decision-Support Tool to Enhance Care of Veterans Diagnosed With Prostate Cancer.一种用于加强前列腺癌确诊退伍军人护理的系统工程与决策支持工具。
Fed Pract. 2016 Feb;33(Suppl 1):57S-60S.
2
Patients' perceptions and attitudes on recurrent prostate cancer and hormone therapy: Qualitative comparison between decision-aid and control groups.患者对复发性前列腺癌和激素治疗的认知与态度：决策辅助组与对照组的定性比较
J Geriatr Oncol. 2017 Sep;8(5):368-373. doi: 10.1016/j.jgo.2017.05.006.
3
Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.接触橙剂、越战退伍军人与前列腺癌风险
Cancer. 2008 Nov 1;113(9):2464-70. doi: 10.1002/cncr.23695.
4
Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care.退伍军人健康管理局内 21 基因复发分数检测的临床影响：利用和获得符合指南的护理。
Clin Breast Cancer. 2018 Apr;18(2):135-143. doi: 10.1016/j.clbc.2017.11.018. Epub 2017 Nov 29.
5
Contemporary nationwide patterns of self-reported prostate-specific antigen screening in US veterans.美国退伍军人中自我报告的前列腺特异性抗原筛查的当代全国模式。
Urol Oncol. 2015 Dec;33(12):503.e7-15. doi: 10.1016/j.urolonc.2015.07.019. Epub 2015 Aug 28.
6
The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.前列腺癌干预与观察试验：一项比较根治性前列腺切除术与期待治疗对临床局限性前列腺癌治疗效果的随机试验。
J Urol. 1994 Nov;152(5 Pt 2):1910-4. doi: 10.1016/s0022-5347(17)32413-8.
7
Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.澄清早期前列腺癌检测与治疗方面的不确定性。
Semin Urol Oncol. 2002 Feb;20(1):10-7. doi: 10.1053/suro.2002.30393.
8
Development of an Educational Strategy and Decision Support Tool to Enhance Appropriate Use of Stress Echocardiography at a Large Academic Medical Center: A Prospective, Pre- and Postintervention Analysis.在大型学术医疗中心开发一项教育策略和决策支持工具，以增强应激超声心动图的合理使用：一项前瞻性、干预前后分析。
J Am Soc Echocardiogr. 2015 Dec;28(12):1401-9. doi: 10.1016/j.echo.2015.08.003. Epub 2015 Sep 8.
9
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.提高诊断为前列腺癌的退伍军人的风险分层：17 基因前列腺评分检测的影响。
Am J Manag Care. 2018 Jan;24(1 Suppl):S4-S10.
10
User-testing an interactive option grid decision aid for prostate cancer screening: lessons to improve usability.用户测试交互式选项网格决策辅助工具在前列腺癌筛查中的应用：提高可用性的经验教训。
BMJ Open. 2019 May 27;9(5):e026748. doi: 10.1136/bmjopen-2018-026748.
本文引用的文献
1
Appointment "no-shows" are an independent predictor of subsequent quality of care and resource utilization outcomes.预约“爽约”是后续医疗质量和资源利用结果的独立预测因素。
J Gen Intern Med. 2015 Oct;30(10):1426-33. doi: 10.1007/s11606-015-3252-3. Epub 2015 Mar 17.
2
Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement.前列腺癌生存者照护指南：美国临床肿瘤学会临床实践指南支持声明。
J Clin Oncol. 2015 Mar 20;33(9):1078-85. doi: 10.1200/JCO.2014.60.2557. Epub 2015 Feb 9.
3
Patient navigation based on predictive modeling decreases no-show rates in cancer care.基于预测模型的患者导航可降低癌症护理中的失约率。
Cancer. 2015 May 15;121(10):1662-70. doi: 10.1002/cncr.29236. Epub 2015 Jan 13.
4
The PSA tracker: a computerised health care system initiative in Northern Ireland.前列腺特异性抗原追踪器：北爱尔兰的一项计算机化医疗保健系统计划。
Ulster Med J. 2013 Sep;82(3):146-9.
5
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group.根治性治疗的低危、中危和高危前列腺癌患者前列腺特异性抗原无复发生存结果的比较分析。前列腺癌结果研究组的结果。
BJU Int. 2012 Feb;109 Suppl 1:22-9. doi: 10.1111/j.1464-410X.2011.10827.x.
6
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference.对于临床局限性前列腺癌男性患者，在接受或未接受激素治疗的情况下，定义放疗后的生化复发：美国放射肿瘤学组（RTOG）-美国放射肿瘤学会（ASTRO）凤凰城共识会议的建议
Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):965-74. doi: 10.1016/j.ijrobp.2006.04.029.
7
Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.前列腺癌根治术后生化复发接受或未接受激素治疗情况下挽救性放疗的结果
Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):134-40. doi: 10.1016/j.ijrobp.2005.01.020.
8
Radiation therapy for increasing prostate-specific antigen levels after radical prostatectomy.根治性前列腺切除术后放疗用于提高前列腺特异性抗原水平
Clin Prostate Cancer. 2003 Mar;1(4):235-41. doi: 10.3816/cgc.2003.n.005.
9
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy.前列腺癌根治术后复发性前列腺癌的挽救性放疗
JAMA. 2004 Mar 17;291(11):1325-32. doi: 10.1001/jama.291.11.1325.
10
Salvage radiation for a rising PSA following radical prostatectomy.前列腺癌根治术后PSA升高时的挽救性放疗。
Urol Oncol. 2004 Jan-Feb;22(1):50-6. doi: 10.1016/j.urolonc.2003.12.001.
Zotero 插件